A business in context

ORGO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338321 · Items 1.01,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338049

  3. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338022 · Items 2.02,9.01

  4. 8-K · Current report

    Report date 2026-06-15 · 0001193125-26-272710 · Items 5.02,5.07

  5. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001661181-26-000008

  6. 8-K · Current report

    Report date 2026-05-07 · 0001661181-26-000007 · Items 2.02,9.01

  7. DEF 14A · Proxy statement

    Report date 2026-06-15 · 0001193125-26-197357

  8. 4 · Ownership change

    Report date 2025-01-10 · 0002064832-26-000183

  9. 4 · Ownership change

    Report date 2026-03-09 · 0002064832-26-000129

  10. 4 · Ownership change

    Report date 2026-03-09 · 0002064832-26-000127

  11. 4 · Ownership change

    Report date 2026-03-01 · 0002064832-26-000093

  12. 4/A · Ownership change

    Report date 2026-02-18 · 0002064832-26-000092

  13. 4/A · Ownership change

    Report date 2026-02-18 · 0002064832-26-000091

  14. 4/A · Ownership change

    Report date 2026-02-18 · 0002064832-26-000090

  15. 4/A · Ownership change

    Report date 2026-02-18 · 0002064832-26-000089

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076730

  17. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-076595 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-02-18 · 0001193125-26-064270 · Items 5.02

  19. 8-K · Current report

    Report date 2025-12-22 · 0001193125-25-335425 · Items 1.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269697

  21. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-269654 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-09-25 · 0001193125-25-217810 · Items 7.01,8.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105048

  24. 8-K · Current report

    Report date 2025-08-05 · 0000950170-25-105032 · Items 1.01,2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-23 · 0001193125-25-145767 · Items 5.02,5.07

  26. DEF 14A · Proxy statement

    Report date 2025-06-23 · 0001193125-25-117808

  27. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066962

  28. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066930 · Items 2.02,9.01

  29. 10-K/A · Annual report

    Report date 2024-12-31 · 0001193125-25-104050

  30. 8-K · Current report

    Report date 2025-03-27 · 0001193125-25-065638 · Items 7.01,9.01

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-029137

  32. 8-K · Current report

    Report date 2025-02-27 · 0000950170-25-029021 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2024-11-27 · 0000950170-24-132248 · Items 1.01,9.01

  34. 8-K · Current report

    Report date 2024-11-18 · 0000950170-24-130202 · Items 1.01,8.01,9.01

  35. SC 13D · Ownership disclosure

    0001193125-24-261721

  36. SC 13G/A · Ownership disclosure

    0001213900-24-098337

  37. SC 13D/A · Ownership disclosure

    0001193125-24-259026

  38. 8-K · Current report

    Report date 2024-11-12 · 0001193125-24-256699 · Items 1.01,2.04,3.02,3.03,5.02,5.03,8.01,9.01

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-125431

  40. 8-K · Current report

    Report date 2024-11-12 · 0000950170-24-125331 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001661181Organogenesis Holdings Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • Avista Healthcare Public Acquisition Corp. · former SEC name · 2015-12-18 to 2018-12-10

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$482.04M$517.76M
2023-12-31$433.14M$478.94M
2022-12-31$450.89M$519.04M
2021-12-31$467.36M$581.04M
2020-12-31$338.30M$440.42M
2019-12-31$260.98M$343.94M
2018-12-31$193.45M$259.56M
2017-12-31$198.51M$272.86M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗